Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
- PMID: 26648535
- PMCID: PMC4895156
- DOI: 10.1038/leu.2015.338
Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
Figures

References
-
- Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 2015; 33: 657–664. - PubMed
-
- Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS et al. Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 2014; 28: 1902–1908. - PubMed
-
- Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A et al. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood 2011; 118: 5989–5995. - PubMed
-
- Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007; 92: 50–55. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical